Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
genetic toxicity in vivo
Adequacy of study:
other information

Data source

Reference
Title:
No information
Author:
Monsanto Co. (1983) |Report HL-83-195|In-vivo bone marrow chromosome study in rats.|US EPA/OPTS Public files No. 878216400

Materials and methods

Principles of method if other than guideline:
Method: other: US EPA Health Effects guidelines, EPA Report 560/5-83-001.
GLP compliance:
yes
Type of assay:
other: In vivo cytogenetics chromosomes abberation assay.

Test material

Constituent 1
Chemical structure
Reference substance name:
2-hydroxy-2-methylpropionitrile
EC Number:
200-909-4
EC Name:
2-hydroxy-2-methylpropionitrile
Cas Number:
75-86-5
Molecular formula:
C4H7NO
IUPAC Name:
2-hydroxy-2-methylpropanenitrile
Details on test material:
IUCLID4 Test substance: as prescribed by 1.1 - 1.4

TS-Freetext:
98.5% Acetone cyanohydrin. Certificate of analysis.

Test animals

Species:
rat
Strain:
Sprague-Dawley

Administration / exposure

Route of administration:
oral: gavage
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 1.5 & 15 mg/kg
Basis:

Results and discussion

Applicant's summary and conclusion

Executive summary:

NOTE: Any of data in this dataset are disseminated by the European Union on a right-to-know basis and this is not a publication in the same sense as a book or an article in a journal. The right of ownership in any part of this information is reserved by the data owner(s). The use of this information for any other, e.g. commercial purpose is strictly reserved to the data owners and those persons or legal entities having paid the respective access fee for the intended purpose.